Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2019
Melbourne's Peter MacCallum Cancer Centre to be home of 'the next great wave in treatment'
25 March 2019 - A new form of cancer treatment that uses cell therapy to attack the disease will become ...
Posted by Michael Wonder on 14 Mar 2019
Institute for Clinical and Economic Review releases draft evidence report on siponimod for treating secondary progressive multiple sclerosis
14 March 2019 - Public comment period now open until 10 April 2019; requests to make oral comment during public meeting ...
Posted by Michael Wonder on 14 Mar 2019
One in four cancer patients wait two months for treatment, as NHS performance hits record low
14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...
Posted by Michael Wonder on 14 Mar 2019
The Liberals’ plan for Pharmacare? We’re still waiting
14 March 2019 - The Trudeau government is edging closer to announcing its proposals for some kind of national drug ...
Posted by Michael Wonder on 14 Mar 2019
Patient advocates applaud Cancer Drug Parity Act filed in both the U.S. House and Senate
13 March 2019 - The Coalition to Improve Access to Cancer Care and its members from across the cancer patient ...
Posted by Michael Wonder on 14 Mar 2019
An EU wide approach to HTA: an irrelevant development or an opportunity not to be missed?
14 March 2019 - An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness ...
Posted by Michael Wonder on 14 Mar 2019
European Commission approves Merck’s Keytruda (pembrolizumab) in combination with chemotherapy for first-line treatment of adults with metastatic squamous non-small cell lung cancer
14 March 2019 - European approval based on KEYNOTE-407 study results demonstrating significant improvement in overall survival with Keytruda in combination ...
Posted by Michael Wonder on 14 Mar 2019
European Commission approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors
14 March 2019 - First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis, in a prospective intra-patient ...
Posted by Michael Wonder on 14 Mar 2019
UK breast cancer patients win early access to Tecentriq/nab-paclitaxel
14 March 2019 - Adults in the UK with PD-L1 positive, unresectable locally advanced or metastatic triple-negative breast cancer have ...
Posted by Michael Wonder on 14 Mar 2019
House Democrats investigate Trump backed short-term health plans
14 March 2019 - Energy & Commerce Chairman Pallone writes 12 insurance firms. ...
Posted by Michael Wonder on 14 Mar 2019
Statement by FDA Commissioner on new strategies to modernise clinical trials to advance precision medicine, patient protections and more efficient product development
14 March 2019 - Modernizing clinical trials is an agency wide priority. ...
Posted by Michael Wonder on 14 Mar 2019
CMS updates drug dashboards with prescription drug pricing and spending data
14 March 2019 - Dashboards further the agency’s efforts to increase price transparency throughout the healthcare system and create incentives ...
Posted by Michael Wonder on 14 Mar 2019
How Eli Lilly’s new generic insulin could impact prices across the market
14 March 2019 - The list price is $137.35 per vial. ...
Posted by Michael Wonder on 14 Mar 2019
FDA grants Purdue Pharma’s nalmefene hydrochloride injection fast track designation for the emergency treatment of known or suspected opioid overdose
13 March 2019 - Committed to advancing solutions to the opioid public health crisis, Purdue will not profit from nalmefene hydrochloride. ...
Posted by Michael Wonder on 13 Mar 2019
Cancer patient denied life-prolonging drug as she lives half a mile outside England
13 March 2019 - A seriously ill mum-of-two has spoken of her devastation after being denied a life prolonging cancer drug ...
Posted by Michael Wonder on 13 Mar 2019
Pharma urges politicians to stop no-deal Brexit in today’s vote
13 March 2019 - Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that ...